PRISMATICS Competitors

Today's most complex therapies in oncology, rare disease, and specialty biologics have evidence journeys that are long and stakeholders that are sophisticated. But the industry meant to move them forward still operates in two halves: science on one side, commercialization on the other. Somewhere in the handoff, context gets lost. This is the gap Klick Health and Oxford PharmaGenesis are joining forces to close. Klick Health is the world's largest independent commercialization partner for life sciences, focused on developing, launching, and supporting brands to achieve their full potential. Oxford PharmaGenesis is the leading HealthScience communications consultancy, renowned for scientific communications, medical affairs, publications strategy, and market access consulting. Together, we bring 60 combined years of independence, scientific credibility, and delivery excellence. Over 500 advanced degree holders. 2,100 experts now work seamlessly together, carrying scientific rigor and commercial fluency across the full lifecycle, without compromise. Two legacies. One standard of excellence. Bonded by breakthroughs.

DDBH aims to create a world where the best treatment is possible for every person. To do great work, our teams must work together towards one collective goal: to help HCPs and caregivers deliver the quality care their patients need. DREAM DDB Health reimagines what’s possible in the lives of our patients, asks tough questions to achieve the best result, and works to become experts across many disease states. DARE A bold approach takes our problem solving to a whole new level. A foundation based on teamwork dares to put creative work up to the challenge, and a team to support the work from start to finish. CARE Finding inventive ways to understand our partnerships with patients, HCPs, and caregivers can help us establish an empathetic approach to everything we do. There’s no limit to what we can dream up. We believe that heath can’t wait and that’s why we dare to do boldly.

AREA 23, part of Omnicom Health, is a full-service agency focused on pushing creativity and invention in healthcare marketing to new heights. Its “What If” way of working provides a framework for breakthrough ideas that truly drive innovation and keep clients ahead of industry trends. AREA 23 is consistently recognized with the highest industry awards and honors. Med Ad News named AREA 23 “Agency of the Year,” “Most Creative Agency,” and “Most Admired Agency” in 2017—the first time any agency had won the show’s top three awards at once. That is, until AREA 23 did it again in 2018, 2020, and most recently, in 2023. In all, Med Ad News has honored AREA 23 five times as “Agency of the Year,” nine times as “Most Creative Agency,” and eight times as “Most Admired Agency.” In 2019, Clio Health awarded AREA 23 “Agency of the Year” for a third consecutive year, and New York Festivals Global Awards recognized AREA 23 as “Global Agency of the Year.” Cannes Lions, the world’s preeminent annual creative awards festival, awarded AREA 23 the Innovation Grand Prix. At the Medical Marketing & Media (MM+M) Awards, AREA 23 won “Large Agency of the Year” and the Titanium Award for Best in Show. In 2020/2021, Cannes Lions Health honored the agency with its rarely-awarded Pharma Grand Prix, the Radio & Audio Grand Prix, and recognized AREA 23 as “Agency of the Year.” In 2022, AREA 23 won Clio Health "Agency of the Year,” LIA "Health Agency of the Year," "Large Agency of the Year" at the MM+M Awards, “Most Innovative Culture” by Digiday’s WorkLife Awards, and awarded the Grand Prix for Good and "Agency of the Year" at Cannes Lions Health. This is the third time AREA 23 has earned the coveted title within a five-year span, and the first agency to achieve the feat in successive years. AREA 23’s groundbreaking creative is also celebrated in diverse categories, including Brand Experience & Activation, Creative Strategy, Design, Direct, Mobile, and PR.